Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Discovery of a new genetic mechanism responsible for cardiac hypertrophy

A research network with Catalan participation and in which have worked researchers from seven countries has discovered how to control cardiac hypertrophy, increased heart weight that may lead to heart failure, a major cause of death and disability worldwide. This study, which was coordinated by Dr.

News

Delegates of Mondragon visit VHIR to initiate collaborative works between the two entities

After the cooperation agreement signed on 4 July between Mondragon Health and Vall d'Hebron to collaborate in the field of R+D+I, representatives of the Basque company have visited Vall d'Hebron Research Institute (VHIR) to begin the working sessions between the two entities. By Mondragon were prese

News

4th SMD Integrated Diagnostic Workshop

Units of Cytology, Immunophenotype and cytogenetics of Hematology from Hospital Vall d'Hebron organized on October 5 the fourth Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases.The workshop third edition, led by Dr Teresa Vallespí, hematologist of Vall d'Hebron Resea

News

Dr. Ricard Pujol reflects on the Nobel Prize in Medicine 2011

Nobel Prize in Medicine 2011 recognize key contributions that have revolutionized immunology over the last 15 years It's a truism that science advances with each change of paradigm, but it's true, and this year's honorees have been key players in a very significant change in the conception of the fu

News

Chat with Dr. Rafael Esteban Mur at 'Diario Médico' about the World Hepatitis C Day

Dr Rafael Esteban Mur, member of hepatic disease group at Vall d'Hebron Research Institute (VHIR) and head of internal medicine-liver service at Vall d'Hebron University Hospital, answered questions today in a chat about Hepatitis C in the journal 'Diario Médico' coinciding with the World Day of thi

News

Dr. Montalban debates on research in Multiple Sclerosis at TVE

Dr. Xavier Montalban, head of clinical neuroimmunology group at Vall d'Hebron Research Institute (VHIR) and the Multiple Sclerosis Center of Catalonia (CEM-Cat) has participated in a discussion of multiple sclerosis at TVE in the show 'Para todos la 2'. They have also intervened Dr. Pablo Villoslada

News

VHIR participates in the official start of EATRIS to developing Europe's translational research of the future

Today marks the official start of EATRIS, a pan-European network of translational research infrastructure in medicine. Building on a successful commencement phase funded by the European Commission in 2007-2010, Germany, Finland, Denmark, Italy, Spain and the Netherlands are parties to the new agree

News

The Princess of Asturias presents a cancer research grant from the AECC to Dr. Reventós

Her Royal Highness the Princess of Asturias, Letizia Ortiz, permanently President of Honor of the Spanish Association Against Cancer (AECC) has presented the Cancer Research Grants awarded by the Science Foundation of the AECC in the institutional event that has taken place in Zaragoza. One of the g

News

Identified key mechanisms in the biology of tumor stem cells

A team of researchers from Vall d'Hebron Research Institute (VHIR) has identified the mechanism used by cancer stem cells to protect against external attacks, the establishment of mechanisms of resistance and prevent differentiation to preserve its ability pluripotent, the ability to become any cell

News

VHIR participates in the III MTN Workshop

On 27 and 28 September took place in one of the rooms of the FC Barcelona Camp Nou stadium the III MuscleTech Workshop, which aims to improve the quality of life for people with muscle diseases and reduce the number of sports injuries with improved tools for tendinopathies. The network, called 'Musc

News

VHIR's Heart Area at the World Heart Day

The World Heart Day is an opportunity to increase the awareness of the population and of the administrations, politicians, productive sector and social agents of the enormous medical and economical burden of heart diseases in our society and in the world. A single heart disease, coronary artery dise

News

Members of the Russian Society of Ophthalmology attend a seminar by Dr. Simo at VHIR

More than 50 members of the Russian Society of Ophthalmology attended on Thursday September 22 a seminar by Dr. Rafael Simó, head of diabetes and metabolism group of Vall d'Hebron Research Institute (VHIR) at he conference room of the hospital. The group, formed by the most prestigious Russian eye s

News

The Spanish Society of Probiotics and Prebiotics is created with leadership of VHIR’s researchers

On September 21 was created the Spanish Society for Probiotics and Prebiotics (SEPyP), at Vall d’Hebron University Hospital, host of the new entity. The society will be chaired by Dr. Francisco Guarner, and in its board also will be Dr. Fernando Azpiroz, member and responsable respectively of the di

News

VHIR achieves a high success rate in the call for ISCIII health research projects

Vall d'Hebron Research Institute (VHIR) is the second Catalan biomedical center with more projects awarded in the call for health research projects in 2011 of the Instituto de Salud Carlos III (ISCIII). VHIR has been granted in 27 of its 55 projects presented, representing 49.09% of the success rate

News

Dr. Boada at World Alzheimer's Day

Coinciding with World Alzheimer's Day, Dr. Mercè Boada, head of the group of Alzheimer at Vall d'Hebron Research Institute (VHIR) and director of the ACE Foundation has participated in the program 'Els Matins' of TV3, and has been interviewed for various stories in other media. In addition, Dr. Boad

News

Bisphenol A disrupts the development of ovules in vitro and may increase the risk of Down syndrome

Researchers at the Universitat Autònoma of Barcelona in collaboration with the Department of Obstetrics and Fetal Tissue Bank from Vall d'Hebron University Hospital have analyzed the effects of Bisphenol A (BPA), a polymer widely used for the manufacture of plastics, crop ovaries in vitro. This work

News

VHIR Predoctoral Fellowships

Programa d’ajuts predoctorals per a la formació de personal investigador del Vall d’Hebron Institut de RecercaObjecte: selecció de 4 candidats per realitzar treballs de recerca dins del camp de la recerca biomèdica bàsica, clínica, epidemiològica, així com en gestió i avaluació de serveis i tecnolog

News

VHIR's director meets with the Minister Garmendia as general secretary of COSCE

Dr. Joan Comella, director of the Vall d'Hebron Research Institute (VHIR), met on the afternoon of September 12 the Minister of Science and Innovation, Cristina Garmendia, in his role of secretary general of the Confederation of Scientific Societies of Spain (COSCE), along with its president Carlos

News

Discovered a new mechanism that regulates priority cell signaling pathways

Researchers at Vall d'Hebron Research Institute (VHIR) have discovered a new cellular signaling mechanism that had been unknown until this moment. It is the coordinated use of two languages that are used by the cell to send internal signals in a precise and targeted way. This mechanism does not repl

News

Dr. Pozo explains the latest advances in headache

Coinciding with the World Headache Day, Dr. Patricia Pozo Rosich, leaders of research group in headache and neurological pain at Vall d'Hebron Research Institute (VHIR ) explains the latest research on this subject in the news on TVE. Three and a half million of the Spanish population suffers migrai